Literature DB >> 11291380

Risk of infection from needle reuse at a phlebotomy center.

T C Porco1, T J Aragón, S E Fernyak, S H Cody, D J Vugia, M H Katz, D R Bangsberg.   

Abstract

OBJECTIVES: This study determined infection risk for HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) from needle reuse at a phlebotomy center that possibly exposed 3810 patients to infection.
METHODS: We used a model for the risk of infection per blood draw, supplemented by subsequent testing results from 1699 patients.
RESULTS: The highest risk of transmission was for HBV infection: 1.1 x 10(-6) in the best case and 1.2 x 10(-3) in the (unlikely) worst case. Subsequent testing yielded prevalence rates of 0.12%, 0.41%, and 0.88% for HIV, HBV, and HCV, respectively, lower than National Health and Nutrition Examination Survey III prevalence estimates.
CONCLUSIONS: The infection risk was very low; few, if any, transmissions are likely to have occurred.

Entities:  

Mesh:

Year:  2001        PMID: 11291380      PMCID: PMC1446637          DOI: 10.2105/ajph.91.4.636

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  24 in total

1.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

2.  Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus.

Authors:  L S Martin; J S McDougal; S L Loskoski
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

3.  Occupational exposure to human immunodeficiency virus and hepatitis B virus: a comparative analysis of risk.

Authors:  D K Owens; R F Nease
Journal:  Am J Med       Date:  1992-05       Impact factor: 4.965

4.  Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity.

Authors:  B G Werner; G F Grady
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

5.  Acquired immunodeficiency syndrome in Romania.

Authors:  B S Hersh; F Popovici; R C Apetrei; L Zolotusca; N Beldescu; A Calomfirescu; Z Jezek; M J Oxtoby; A Gromyko; D L Heymann
Journal:  Lancet       Date:  1991-09-14       Impact factor: 79.321

6.  Risk of seroconversion for acquired immunodeficiency syndrome (AIDS) in San Francisco health workers.

Authors:  A Moss; D Osmond; P Bacchetti; J Gerberding; J Levy; J Carlson; C Casavant
Journal:  J Occup Med       Date:  1986-09

7.  Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study.

Authors:  L B Seeff; E C Wright; H J Zimmerman; H J Alter; A A Dietz; B F Felsher; J D Finkelstein; P Garcia-Pont; J L Gerin; H B Greenlee; J Hamilton; P V Holland; P M Kaplan; T Kiernan; R S Koff; C M Leevy; V J McAuliffe; N Nath; R H Purcell; E R Schiff; C C Schwartz; C H Tamburro; Z Vlahcevic; R Zemel; D S Zimmon
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

8.  Hepatitis C virus infection in medical personnel after needlestick accident.

Authors:  T Mitsui; K Iwano; K Masuko; C Yamazaki; H Okamoto; F Tsuda; T Tanaka; S Mishiro
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

9.  Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.

Authors:  J I Tokars; R Marcus; D H Culver; C A Schable; P S McKibben; C I Bandea; D M Bell
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

10.  Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel.

Authors:  M E Hernandez; M Bruguera; T Puyuelo; J M Barrera; J M Sanchez Tapias; J Rodés
Journal:  J Hepatol       Date:  1992-09       Impact factor: 25.083

View more
  1 in total

1.  Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Authors:  Meghan D Morris; Jennifer Evans; Martha Montgomery; Michelle Yu; Alya Briceno; Kimberly Page; Judith A Hahn
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.